Centre members win $29 m in national health research funding
Media release
Maurice Wilkins Centre for Molecular
Biodiscovery
A Centre of Research Excellence hosted by
The University of Auckland
6 June 2013
Centre members win $29 million in national health research funding round
The Maurice Wilkins Centre for Molecular Biodiscovery is delighted that members of its national research network have received a total of $29 million in the annual Health Research Council of New Zealand funding round; almost half the amount awarded this year.
The grants will support research on a wide range of topics from designing new drugs for cancer to modelling heart failure and arrhythmia (abnormal electrical rhythm) and understanding the role of the immune system in allergic disease.
The funding includes four programme grants of almost $5 million each over five years – including two awarded to Maurice Wilkins Centre principal investigators Professors William Denny and Peter Hunter – and eight project grants of around $1 million each over three years. The lead researchers are based at The University of Auckland, University of Otago, and Malaghan Institute of Medical Research.
The Health Research Council supports research that has the potential to improve health outcomes and delivery of healthcare, and to produce economic gain for New Zealand. Grants awarded to members of the Maurice Wilkins Centre network in the 2013 annual funding round include:
Programmes:
Professor William Denny, The
University of Auckland
Rational design of kinase
inhibitors to target cancer
60 months,
$4,923,458
Professor Peter Hunter, The University of
Auckland
Mapping determinants of arrhythmia in structural
heart disease
60 months, $4,993,669
Professor Graham Le
Gros, Malaghan Institute of Medical
Research
Immunotherapy of allergic diseases
60 months,
$4,999,796
Professor Andrew Mercer, University of Otago,
Dunedin
Exploiting the therapeutic potential of
viruses
60 months, $4,937,329
Projects:
Professor
Antony Braithwaite, University of Otago, Dunedin
Does the
D133p53 isoform promote cancer invasion and
metastasis?
36 months, $1,185,648
Associate Professor
Alan Davidson, The University of Auckland
Understanding
kidney injury and the role of HNF1beta
36 months,
$884,664
Associate Professor Alan Davidson, The University
of Auckland
Understanding how WT1 and its binding partner
WTX cause renal disease
36 months, $1,171,726
Professor
David Grattan, University of Otago, Dunedin
Role of
kisspeptin in hyperprolactinemia-induced infertility
36
months, $1,164,184
Dr Deborah Hay, The University of
Auckland
Adrenomedullin 1 receptor antagonists as novel
anti-angiogenic agents
36 months, $1,199,853
Professor
Martyn Nash, The University of Auckland
Characterising
heart failure with clinical imaging and structure-based
modelling
36 months, $1,183,076
Professor Franca
Ronchese, Malaghan Institute of Medical
Research
Conditioning dendritic cells for allergic immune
responses
36 months, $1,199,956
Dr Jeffrey Smaill, The
University of Auckland
Novel small molecule therapeutics
for treatment of smoking-related lung cancer
36 months,
$1,180,810
Notes
The Maurice Wilkins Centre is New Zealand’s Centre of Research Excellence for the discovery of new treatments and diagnostics for human disease. It brings together leading biologists, chemists, and computer scientists to target serious diseases, focusing on infectious disease, cancer and diabetes. It includes researchers with world-class reputations for designing new drugs for these diseases, several of which are in clinical trials.
The Maurice Wilkins Centre is hosted by The
University of Auckland and incorporates researchers from six
New Zealand Universities, three Crown Research Institutes
and a private research institute: The University of
Auckland, University of Otago, Victoria University,
University of Waikato, University of Canterbury, Massey
University, Industrial Research Limited, Plant & Food
Research, AgResearch, and the Malaghan Institute of Medical
Research.
www.mauricewilkinscentre.org
ENDS